Search

You searched for "cosmeceuticals"

69 results found

Defeating dry skin

16 June 2016 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
The author provides a comprehensive overview of the factors influencing skin condition, exploring the physiological processes affecting hydration, the role of ceramides as well as epidermal aquaporins. A detailed and referenced discussion is conveyed on the intrinsic and extrinsic factors...

A review of plasma medicine

1 February 2019 | | PMFA - Aesthetic Medicine, PMFA - Dermatology, PMFA - Oculoplastic
The author investigates the efficacy and tolerability of plasma treatments and asks what the future might hold in this field. Plasma medicine, a new and revolutionary technology to aesthetics, utilises the physical process of sublimation for therapeutic purposes. Non-surgical clinical...

Sinclair presents Sculpt&Shape® at IMCAS Paris 2023

1 February 2023 | Research & Development, Awards, Conferences & Anniversaries
Sinclair, formally Sinclair Pharma (“Sinclair”, www.sinclair.com) a global aesthetics company headquartered in London and fully owned subsidiary of Huadong Medicine Corporation Limited presents Sculpt&Shape® at the IMCAS 2023 congress in Paris.

An overview of chemical peel formulations

7 October 2020 | | PMFA - CPD, PMFA - Aesthetic Medicine, PMFA - Dermatology, PMFA - Facial Plastic Surgery, PMFA - Oculoplastic
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Chemical peels continue to be one of the most popular aesthetic treatments....

The impact of 21st century stressors and lifestyle factors on skin ageing

4 February 2025 | | PMFA - Dermatology, PMFA - Aesthetic Medicine
Skin appearance and health play a significant role in everyone’s life and confidence, particularly in today’s 21st century lifestyle and the associated stressors promoting skin ageing. The skin is a dynamic organ, showing apparent signs of ageing and damage, which...

Exosomes: everything you always wanted to know and questions to ask your exosome provider

4 December 2023 | | PMFA - CPD, PMFA - Aesthetic Medicine
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. What are exosomes? Exosomes are just one subset of extracellular vesicles (EVs),...

V-Series

2 July 2024 | Research & Development
The most adaptable platform on the market is the V-SERIES line of devices. This cutting-edge Multi-Technology platform, created to address a variety of skin issues in daily practice, combines...

Cord lining mesenchymal stem cell exosomal proteins and their effects on hair follicles

4 December 2023 | | PMFA - Aesthetic Medicine
Umbilical cord lining (UCL) mesenchymal stem cells (MSC) produce proteins and growth factors that, when packaged into exosomes in fixed proportions, can stimulate repair and regeneration in recipient cells. The pleiotropic properties of UCL-MSC have been shown to be effective...

Sinclair presents Sculpt&Shape® at AMWC Mónaco 2023

8 March 2023
Sculpt&Shape® is an innovative RotateRF technology device for full body contouring and face rejuvenation. Its different tips and modes combined with the real time temperature control...

How I Do It - The original Blue Peel

1 August 2015 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
The original Blue Peel is a highly controlled, trichloroacetic acid (TCA)-based device procedure, which was created to augment the results achieved with the Obagi Nu-Derm® skin health transformation system. The peel process, including the preparation of skin, application, as well...

Agorà Congress 2025

9 October 2025 -11 October 2025
Founded in 1984, Agorà is a leading scientific society in Aesthetic Medicine, dedicated to promoting evidence-based practice, safety, and clinical excellence. Since 1998, the Agorà International Congress has been a key platform for the exchange of cutting-edge research, innovative methodologies,...

Recurrent corneal erosions secondary to isotretinoin use

4 March 2021 | | PMFA - Dermatology
This article originally appeared in Eye News Dec/Jan 2021 Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations,...